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Wong type dermatomyositis describes a small group of patients with dermatomyositis clinically pre-
sented with pityriasis rubra pilaris-like eruptions, including diffuse palmoplantar hyperkeratosis and
follicular hyperkeratosis. Histopathologic ﬁndings include follicular hyperkeratosis and arrector pili
myositis. There have been 20 cases reported since Wong’s large series. We report a 56-year-old male with
overlap syndrome of Wong type dermatomyositis and rheumatoid arthritis. He also fulﬁlled the criteria
of anti-tRNA synthetase syndrome due to the presence of anti-Jo-1 antibody and clinical features of both
rheumatoid arthritis and myositis. No internal malignancy was found after a complete systemic survey
and within 1 year follow-up period. There was a good response to oral steroid therapy.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Dermatomyositis is an idiopathic inﬂammatory myopathy with
cutaneous manifestations. Characteristic ﬁndings include Gottron’s
papules, heliotrope rash, shawl sign on the nape, shoulders, and
upper back, and a “V sign” on the V-shaped region of the neck and
upper chest. Other cutaneous ﬁndings include nail changes,
vasculitis, localized lipoatrophy, panniculitis, bullous lesions, and,
rarely, hyperkeratotic skin eruptions.1 Pityriasis rubra pilaris (PRP)
describes a group of uncommon, idiopathic, chronic papulosqu-
amous conditions that are characterized by orange-red scaling
plaques with follicular plugging, perifollicular erythema, and pal-
moplantar hyperkeratosis. A PRP-like eruption has been described
in patients with dermatomyositis.2 We report a 56-year-old man
with dermatomyositis and rheumatoid arthritis who developed
skin eruptions clinically resembling PRP with histologic features of
both dermatomyositis and PRP.e no ﬁnancial or non-ﬁnancial
erials discussed in this article.
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A 56-year-old male patient was referred from the rheumatology
clinic with symptoms of pain in multiple joints, morning stiffness,
muscle weakness, and skin rash for several months. The abduction,
adduction, ﬂexion, and extension of the shoulders and the hips of
the patient were tested, which showed muscle power of 4 for the
shoulders and 3e4 for the hips bilaterally, according to the Medical
Research Council scale. He had difﬁculty raising himself from the
bed, climbing stairs, and was unable to hold heavy objects as usual.
These symptoms were followed by the skin rash 6 months later.
Examination revealed diffuse hyperkeratosis on the bilateral soles
and palms with orange hue (Figure 1A and B), erythematous scaly
patches on the shoulders, back, and knees, puffy ﬁngers,
erythematous patches over the metacarpal and proximal inter-
phalangeal joints (Figure 1C), and follicular papules over the
bilateral knee joints (Figure 1D). This patient did not have other
cutaneous features characteristic of dermatomyositis, such as
heliotrope rash, shawl sign, V sign, or periungual telangiectasia.
Blood tests showed elevated: antinuclear antibody titer 1:640
(normal range: <1:40); anti-SSA: 509 AU/mL (normal range:
<100 AU/mL), anti-SSB: 433 AU/mL (normal range: <100 AU/mL);
rheumatoid factor: 436.0 IU/mL (normal range: <20.0 IU/mL), anti-
Jo-1: 147 AU/mL (normal range: <100 AU/mL); serum creatine
kinase: 606 IU/L (normal range: 38e397 IU/L); aspartate trans-
aminase: 42 IU/L (normal range: 15e41 IU/L), erythrocyten. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Diffuse hyperkeratosis with orange hue on (A) bilateral soles and (B) palms with sharp margins. (C) Scaly reddish patches on dorsum of ﬁngers. (D) Follicular hyper-
keratotic papules (arrow) on the knee.
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dehydrogenase: 307 IU/L (normal range: 98e192 IU/L). Anticyclic
citrullinated peptides and C-reactive protein were within normal
limits, while HLA-B27 was negative.
A skin biopsy obtained from the palm revealed an acanthotic
epidermis overlying with loosely arranged hyperkeratosis
(Figure 2A). There were scattered dyskeratotic corneocytes and
parakeratosis in horizontal and vertical arrays (Figure 2B). Vacuolar
degeneration in the basal cell layer, lymphocyte exocytosis, and
scattered dyskeratotic cells were noted, indicating interface
dermatitis (Figure 2C). There were also focal cornoid lamellas
demonstrated by the loss of the granular layer with a dell in the
epidermis containing a stacked column of horny cells, some
retaining their nuclei (Figure 2D). A mild to moderate lymphocytic
perivascular inﬁltrate was present in the upper dermis. The overall
pathological features presented an unusual combination of inter-
face dermatitis, PRP, and porokeratosis.
A muscle biopsy specimen taken from the left thigh revealed
perivascular lymphocytic inﬁltration and degenerative changes in
the muscle tissue. The needle electromyography showed sponta-
neous activities and low amplitudes, with short duration and
polyphasic motor unit action potentials in the right deltoid, vastus
medialis, and tibialis anterior muscles, suggestive of myopathic
change. A bone scan revealed arthritis involving the bilateral
shoulder and wrist joints, carpi, metacarpal, and proximal inter-
phalangeal joints of both hands.
Proximal muscle weakness, increased serum muscle enzyme,
and typical ﬁndings on electromyography and muscle biopsy re-
sults in our patient were compatible with dermatomyositis. The
unusual clinical and pathological presentations of PRP-like features
indicated Wong type dermatomyositis. Furthermore, according to2010 rheumatoid arthritis (RA) classiﬁcation criteria,2 the patient
had a score of 9/10 (cut off point for deﬁnite RA: 6/10), compatible
with RA. The patient was diagnosed as having overlap syndrome of
dermatomyositis and RA. Due to the positive anti-Jo-1 antibody and
clinical features of rheumatoid arthritis and myositis, our patient
also fulﬁlled the criteria of anti-tRNA synthetase syndrome, a well-
known overlap condition.
A complete malignancy workup was performed. The chest
radiograph showed only increased bilateral lung markings; the
upper gastroendoscopy revealed shallow ulcers in the lower-body
of the stomach. There was positive occult blood, and therefore
the patient had a colonoscopy examination and transrectal poly-
pectomy. A tubular adenoma at the hepatic ﬂexure, and a mixed
tubular adenoma and hyperplastic polyp were removed. No carci-
noma was found. Nasopharyngoscopy and serum tumor markers
including carcinoembryonic antigen, a-fetoprotein, CA19-9, pros-
tate-speciﬁc antigen, EpsteineBarr virus-IgA and EpsteineBarr vi-
rus early antigen, and nuclear antigen IgA were normal.
He was treated with: daily oral prednisolone 30 mg, plaquenil
200 mg, and etoricoxib 60 mg; topical salicylic acid 2.5% oint-
ment twice daily for the palmoplantar lesions and desox-
imetasone 0.25% ointment twice daily for the body. The skin
lesions gradually improved, so the dosage of oral prednisolone
was tapered to 10 mg/day. He did not report muscle weakness
after the prednisolone being tapered. The laboratory data,
including aspartate aminotransferase, lactate dehydrogenase,
erythrocyte sedimentation rate, and serum creatine kinase,
decreased following the treatment. Serum creatine kinase
decreased from 606 IU/L to 66 IU/L. He is now being maintained
on this regimen and regularly followed up at the rheumatology
and dermatology clinics.
Figure 2 (A) A loose hyperkeratotic stratum corneum and acanthosis. (B) High magniﬁcation showed scattered dyskeratotic keratinocytes, parakeratosis in horizontal and vertical
arrays and some dyskeratotic cells in the stratum corneum. (C) Interface dermatitis featured by vacuolar degeneration of basal keratinocytes, lymphocyte exocytosis, and scattered
dyskeratotic cells. (D) Focal cornoid lamella characterized by loss of the granular layer and dyskeratotic keratinocytes beneath the parakeratotic columns (hematoxylin and eosin,
original magniﬁcation, A 40, B 400, C 400, D 200).
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Wong type dermatomyositis refers to a small subgroup of patients
with dermatomyositis present with clinical features more charac-
teristic of PRP; only a few cases have been reported. This entity was
ﬁrst described by O’Leary in 1953 in a patient with dermatomyo-
sitis, erythroderma, and plantar keratoderma.3 Wong subsequently
reported 23 patients of Asian descent with dermatomyositis, of
whom 11 had clinical lesions resembling PRP.3 These lesions were
described as follicular, erythematous, and hyperkeratotic papules
located on the backs of the hands, usually arranged in a linear array
over the bony prominences.3e5 The relatively high occurrence of
the syndrome in South East Asiamay be inﬂuenced by racial factors.
Twenty additional patients have been described since Wong’s se-
ries.3e5 The most characteristic features in these patients were
hyperkeratotic follicular papules, involving at least the extremities.
Other features included generalized erythematous squamous
eruptions, and thick keratinization over acral sites.3e5
The common histologic ﬁndings in these patients were follicular
hyperkeratosis with arrector pili myositis. However, hyperkeratosis
unrelated to hair follicles has also been described.5 Although there
were no demonstrable follicular hyperkeratosis or arrector pili
myositis, due to the biopsy site of the palm in our patient, para-
keratosis in the horizontal and vertical arrays suggested features of
PRP. The cornoid lamella found on histopathology in our patient is
unusual, although it may be an incidental ﬁnding and have no
clinical signiﬁcance. However, therewas one reported case ofWong
type dermatomyositis showing clinical and histologic features
highly suggestive of porokeratosis.3 The incidence of PRP and
porokeratosis-like lesions occurring together is unknown, becausethey are usually asymptomatic and can be easily overlooked on
cutaneous examination.3
Our patient developed symptoms of dermatomyositis and
rheumatoid arthritis, satisfying the criteria of overlap syndrome: at
least two connective tissue diseases occurring at the same or at
different times in the same patient.6 An association of polymyositis/
dermatomyositis with RA has long been established.7 Polymyositis/
dermatomyositis can develop at any stage of RA.8 In recent years,
genomic studies have shown marked overexpression of type I
interferon inducible genes in the peripheral blood of patients with
systemic lupus erythematosus, dermatomyositis, polymyositis,
multiple sclerosis, rheumatoid arthritis, systemic sclerosis, and
Sjögren’s syndrome, indicating that these diseases share activation
of a common type I interferon pathway.9
Our patient also fulﬁlled the criteria of anti-t-RNA synthetase
syndrome. This is awell-known overlap syndrome characterized by
a speciﬁc autoantibody marker that usually has clinical manifes-
tations milder than those observed in patients with any single
connective tissue disease included in overlap syndrome.6 Patients
who produce anti-Jo-1 antibodies less frequently display the classic
manifestations of dermatomyositis. This may be the reason that our
patient had fewer characteristic cutaneous features of dermato-
myositis. About 60e90% of patients affected with anti-Jo-1 positive
anti-t-RNA synthetase syndrome develop symmetric arthritis that
can fulﬁll the 2010 American College of Rheumatology/ European
League Against Rheumatism criteria for RA.6 Interstitial lung
involvement has been described in 50e85% of patients with anti-
Jo-1 antibodies.10,11 Our patient had arthralgia, arthritis, and
myositis; he did not have a fever, Raynaud’s phenomenon, dyspnea,
or any other symptoms/signs of interstitial lung disease. Anti-Jo-1
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anti-Ro/SSA and anti-La/SSB,12 which were also noted in our
patient.
In conclusion, this patient developed a rare overlap syndrome of
Wong type PRP-like dermatomyositis, rheumatoid arthritis. The
clinical and serological features are also consistent with anti-t-RNA
synthetase syndrome. The complex of clinical and histological
manifestations may confuse physicians, and in this case, the
occurrence of multiple connective tissue disorders was not
completely understood. Patients who have had overlap features
with dermatomyositis should be followed for internal malignancy,
as in every case of adult dermatomyositis.
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